Computer-assisted cognitive stimulation for delirium in older adults
Clinical, Demographic and Genetic Factors Associated With Response to Computer-assisted Cognitive Stimulation Treatment as Part of Non-pharmacological Care in Patients With Delirium. Feasibility Study.
This will try adding tablet-based cognitive exercises to sleep and mobility support to see if they reduce delirium in people aged 60 and older in subacute care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Institut Investigacio Sanitaria Pere Virgili Academic / other |
| Locations | 1 site (Reus, Tarragona) |
| Trial ID | NCT07563244 on ClinicalTrials.gov |
What this trial studies
Patients aged 60 and over admitted to a subacute care unit with delirium will receive a package of non-pharmacological therapies focused on regular sleep schedules, increased mobility, and cognitive stimulation. Participants will be divided into two groups: both receive the standard non-drug interventions, and one group also receives twice-daily computer-based cognitive sessions delivered by an occupational therapist on a tablet for one week. Delirium presence and severity will be reassessed after one week, and the study will examine whether individual clinical, laboratory, or demographic factors influence onset, severity, or response to treatment. The trial is conducted at Institut Pere Mata in Reus, Tarragona.
Who should consider this trial
Good fit: Ideal candidates are adults aged 60 or older admitted to the subacute care unit with delirium who can provide consent (or have a legal guardian) and have sufficient vision, hearing, and language ability to use a tablet.
Not a fit: People under 60, those receiving palliative end-of-life care, or those with severe visual or hearing impairment, aphasia, or serious language barriers are unlikely to be eligible or to benefit from the tablet-based intervention.
Why it matters
Potential benefit: If successful, adding computer-guided cognitive sessions could shorten delirium episodes and speed recovery in older adults receiving subacute care.
How similar studies have performed: Multicomponent non-pharmacological programs have reduced delirium incidence in prior research, but using twice-daily tablet-based cognitive training to treat active delirium is relatively novel and less well tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients aged 60 years or over who are admitted to the subacute care center between 15 February and 15 October 2026 and who sign the informed consent (the patient and their family or legal guardians if the patient's cognitive condition prevents them from giving consent themselves) Exclusion Criteria: * Patients who, at the time of admission, meet the criteria for palliative end-of-life care. * Individuals under 60 years of age, to ensure sample homogeneity and reduce confounding factors. * Individuals with severe visual or hearing impairment or aphasia, due to the difficulty of carrying out the cognitive intervention. * Serious communication difficulties due to language.
Where this trial is running
Reus, Tarragona
- Institut Pere Mata — Reus, Tarragona, Spain (Recruiting)
Study contacts
- Study coordinator: Esteban Sepulveda-Ramos, PhD
- Email: esteban.sepulveda@urv.cat
- Phone: +34-977338565
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.